The applicafion of three-dimensional printing personalized polyetheretherketone on alveolar bone augmentation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051397

Enrollment

Unknown

Registered

2021-09-23

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar defect

Interventions

PEEK test group:PEEK stents were implanted

Control group:Implant absorbable collagen membrane

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged>=18 years male or female; 2.Insufficient bone mass in vertical direction of maxillary and mandibular Alveolar Bone; 3.Fit for implant indication; 4.Sufficient cognitive ability to complete the scale independently 5.Voluntarily signed informed consent to participate in the clinical trial.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications for surgery; 2.Pregnant women/breast-feeding patients; 3.Patients with poor coordination; 4.Patients who were not considered suitable by other researchers to participate in the trial; 5.Have a history of head and neck radiation.

Design outcomes

Primary

Measure	Time frame
Vertical and horizontal bone augmentation effects;	—

Secondary

Measure	Time frame
Complication;Percentage of new bone;New bone morphology;	—

Countries

China

Contacts

Public ContactLiu Guolin

Liangxiang Hospital of Beijing Fangshan District

liuguolin0507@126.com+86 13511016953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026